Farmaceutisch concern · India
Cipla
Een concern van 34 bedrijven met 214 geneesmiddelen in 10 landen.
Concernstructuur
34 bedrijven in 8 landen
Laden…
Farmaceutisch concern · India
Een concern van 34 bedrijven met 214 geneesmiddelen in 10 landen.
34 bedrijven in 8 landen
Eén gratis account voor de Prognia-apps: Ward om te studeren, Osler voor klinische antwoorden met hun bronnen, en het netwerk om je collega’s te vinden.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Alle geneesmiddelen van alle bedrijven in het concern, actuele eerst.
1–25 van 214
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| ABIRATERONA CIPLA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | Spanje | In de handel | 2022 |
| acetato de icatibanto | Icatibant | Brazilië | Toegelaten | 2023 |
| ALBUTEROL SULFATE0.09mg base/inh · Aerosol, metered | Salbutamol | Verenigde Staten | In de handel | 2020 |
| AMBRISENTAN10mg | 5mg · Tablet | Ambrisentan | Verenigde Staten | In de handel | 2019 |
| ANAGRELIDE HYDROCHLORIDE0.5mg base | 1mg base · Capsule | Anagrelide | Verenigde Staten | In de handel | 2005 |
| APIXABAN CIPLACompressa rivestita con film | Apixaban | Italië | Toegelaten | |
| Apixaban Cipla 2,5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Nederland | Toegelaten | 2024 |
| Apixaban Cipla 5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Nederland | Toegelaten | 2024 |
| Arquist 125 mikrograma po potisku, stlačeni inhalat, suspenzija*stlačeni inhalat, suspenzija | Fluticasonpropionaat | Kroatië | Niet in de handel | 2020 |
| Arquist 250 mikrograma po potisku, stlačeni inhalat, suspenzija*stlačeni inhalat, suspenzija | Fluticasonpropionaat | Kroatië | Niet in de handel | 2020 |
| ARVALTI 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG20 mg · Comprimido recubierto con película | Tadalafil | Spanje | Toegelaten | 2019 |
| ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)72,5 µg + 250 µg · Polvo para inhalación (unidosis) | Salmeterol, Fluticasone | Spanje | Toegelaten | 2025 |
| ASERIFLU 50 MICROGRAMOS/500 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)72,5 µg + 500 µg · Polvo para inhalación (unidosis) | Salmeterol, Fluticasone | Spanje | Toegelaten | 2025 |
| BEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFG75 mg · Cápsula blanda | Bexarotene | Spanje | In de handel | 2021 |
| BIBECFO 100 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION6 µg + 100 µg · Solución para inhalación en envase a presión | Formoterol, Beclometasone | Spanje | In de handel | 2024 |
| BIBECFO 200 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESION200 µg + 6 µg · Solución para inhalación en envase a presión | Beclometasone, Formoterol | Spanje | In de handel | 2024 |
| BORTECIP | Bortezomib | Brazilië | Toegelaten | 2022 |
| BOSENTAN CIPLA 125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG129,080 mg · Comprimido recubierto con película | Bosentan | Spanje | In de handel | 2016 |
| Bosentan Cipla 125 mg filmom obložene tablete*filmom obložena tableta | Bosentan | Kroatië | Niet in de handel | 2020 |
| BOSENTAN CIPLA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG64,540 mg · Comprimido recubierto con película | Bosentan | Spanje | In de handel | 2016 |
| Bosentan Cipla 62,5 mg filmom obložene tablete*filmom obložena tableta | Bosentan | Kroatië | Niet in de handel | 2020 |
| BUDESONIDA/FORMOTEROL CIPLA 160 MICROGRAMOS/4,5 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)Igual a 194.7 µg µg + Igual a 6.1 µg µg · Polvo para inhalación (unidosis) | Budesonide, Formoterol | Spanje | In de handel | 2018 |
| BUDESONIDA/FORMOTEROL CIPLA 320 MICROGRAMOS/9 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)320 µg + 9 µg · Polvo para inhalación (unidosis) | Budesonide, Formoterol | Spanje | In de handel | 2021 |
| Budesonide/Formoterolfumaraatdihydraat Cipla 200 microgram/6 microgram per dosis, aërosol, suspensieAërosol, suspensie | Budesonide, Formoterol | Nederland | Toegelaten | 2025 |
| CETIRIZINA CIPLA 1 MG/ML SOLUCION ORAL EFG0,10 % p/v · Solución oral | Cetirizina dihidrocloruro | Spanje | In de handel | 2015 |
Waar het geneesmiddelen registreert of maakt, en hoeveel daarvan actueel zijn.
| Land | Geneesmiddelen | Actueel | Vroeger | Bedrijven |
|---|---|---|---|---|
| Spanje | 97 | 60 | 37 | BedrijvenAlle geneesmiddelen |
| Verenigde Staten | 42 | 18 | 24 | BedrijvenAlle geneesmiddelen |
| Brazilië | 23 | 18 | 5 | BedrijvenAlle geneesmiddelen |
| Nederland | 18 | 18 | 0 | BedrijvenAlle geneesmiddelen |
| Saoedi-Arabië | 16 | 16 | 0 | BedrijvenAlle geneesmiddelen |
| Kroatië | 13 | 13 | 0 | BedrijvenAlle geneesmiddelen |
| Europese Unie (EMA) | 2 | 0 | 2 | BedrijvenAlle geneesmiddelen |
| Canada | 1 | 0 | 1 | BedrijvenAlle geneesmiddelen |
| Italië | 1 | 1 | 0 | BedrijvenAlle geneesmiddelen |
| Roemenië | 1 | 0 | 1 | BedrijvenAlle geneesmiddelen |
Ook geregistreerd in: Australië, Colombia, Frankrijk, Maleisië, Singapore, Verenigd Koninkrijk, Zweden
De ATC-groepen waartoe de meeste van zijn geneesmiddelen behoren, grootste eerst.
De werkzame stoffen in de meeste van zijn geneesmiddelen.
Hoe de registers de naam schrijven, genormaliseerd: zonder rechtsvorm, accenten en hoofdletters.
Samengesteld door Prognia uit de openbare geneesmiddelen- en bedrijfsregisters hieronder. Logo’s worden niet gebruikt.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Source: European Medicines Agency (EPAR data).
Licentie: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licentie: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licentie: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licentie: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licentie: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licentie: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licentie: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licentie: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM renovacion; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos, dataset vwwf-4ftk, rowsUpdatedAt 1792152641, acquired 2026-10-26; original values retained.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licentie: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licentie: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licentie: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Licentie: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licentie: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licentie: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licentie: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licentie: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licentie: Singapore Open Data Licence
Meld een fout of vraag verwijdering aanCorrecties van het bedrijf zelf zijn welkom.
Houd de geneesmiddelen van Cipla op Prognia juist, zie hoe zorgprofessionals ze gebruiken en beantwoord wat ze vragen. Een gesprek van 20 minuten, in het Engels.
Plan een gesprekBekende farmaceutische concerns, elk met al zijn bedrijven.
Gerangschikt naar hun aantal geneesmiddelen.